|
ZNF304 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.56929954878649E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.34820005054581E-09 |
| Normal-vs-Stage2 |
8.68330000014517E-07 |
| Normal-vs-Stage3 |
1.32770461291898E-11 |
| Normal-vs-Stage4 |
3.24960058861734E-11 |
| Stage1-vs-Stage2 |
8.342400E-01 |
| Stage1-vs-Stage3 |
1.552610E-01 |
| Stage1-vs-Stage4 |
1.830060E-02 |
| Stage2-vs-Stage3 |
2.889000E-01 |
| Stage2-vs-Stage4 |
8.011700E-02 |
| Stage3-vs-Stage4 |
3.875800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.95809948652948E-10 |
| Normal-vs-AfricanAmerican |
1.634670E-04 |
| Normal-vs-Asian |
1.05519999960002E-07 |
| Caucasian-vs-AfricanAmerican |
4.372000E-01 |
| Caucasian-vs-Asian |
4.319200E-01 |
| AfricanAmerican-vs-Asian |
8.481200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24459997863369E-10 |
| Normal-vs-Female |
4.90759988203138E-10 |
| Male-vs-Female |
4.785200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.3283999455993E-09 |
| Normal-vs-Age(41-60Yrs) |
2.28289998016606E-09 |
| Normal-vs-Age(61-80Yrs) |
4.07220035469891E-10 |
| Normal-vs-Age(81-100Yrs) |
2.821800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.367600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.407800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.689000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.587400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.883600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.914800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.433700E-02 |
| Classical-VS-Follicular |
1.972770E-01 |
| Classical-VS-Other |
3.569800E-01 |
| Classical-VS-Normal |
2.31869999867129E-08 |
| Tall-VS-Follicular |
2.487000E-01 |
| Tall-VS-Other |
9.161000E-01 |
| Tall-VS-Normal |
8.71280048109213E-10 |
| Follicular-VS-Other |
6.654400E-01 |
| Follicular-VS-Normal |
3.51670026432771E-10 |
| Other-VS-Normal |
3.464400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.34843264226947E-12 |
| Normal-vs-N1 |
4.00509625464451E-11 |
| N0-vs-N1 |
4.344400E-02 |
|
|
